Medicinova (MNOV) Goodwill & Intangibles (2010 - 2026)
Medicinova (MNOV) posted quarterly Goodwill & Intangibles of $9.6 million for Q4 2025, little changed year-over-year from $9.6 million in Q4 2024, and little changed quarter-over-quarter from $9.6 million in Q3 2025.
Medicinova (MNOV) Goodwill & Intangibles (2010 - 2026) Analysis & Trends
Medicinova (MNOV) has reported Goodwill & Intangibles for 16 consecutive years, with $9.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Goodwill & Intangibles changed 0.0% year-over-year to $9.6 million; the TTM figure through Dec 2025 stood at $9.6 million (changed 0.0% YoY), while the FY2025 annual figure was $9.6 million, changed 0.0% from the prior year.
- Goodwill & Intangibles held at $9.6 million in Q4 2025 per MNOV's latest filing, from $9.6 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $9.6 million in Q1 2021 and bottomed at $9.6 million in Q1 2021.
- Historically, Goodwill & Intangibles has averaged $9.6 million across 5 years, with a median of $9.6 million in 2021.
- On a YoY basis, Goodwill & Intangibles climbed as much as 0.0% in 2021 and fell as far as 0.0% in 2021.
- Medicinova's Goodwill & Intangibles stood at $9.6 million in 2021, then changed by 0.0% to $9.6 million in 2022, then changed by 0.0% to $9.6 million in 2023, then changed by 0.0% to $9.6 million in 2024, then changed by 0.0% to $9.6 million in 2025.
- Business Quant data shows MNOV's Goodwill & Intangibles at $9.6 million in Q4 2025, $9.6 million in Q3 2025, and $9.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Medicinova | 68.42 Mn | 68.42 Mn | 317,759.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.60 Mn |
| Dec 31, 2025 | 9.60 Mn |
| Sep 30, 2025 | 9.60 Mn |
| Jun 30, 2025 | 9.60 Mn |
| Mar 31, 2025 | 9.60 Mn |
| Dec 31, 2024 | 9.60 Mn |
| Sep 30, 2024 | 9.60 Mn |
| Jun 30, 2024 | 9.60 Mn |
| Mar 31, 2024 | 9.60 Mn |
| Dec 31, 2023 | 9.60 Mn |
| Sep 30, 2023 | 9.60 Mn |
| Jun 30, 2023 | 9.60 Mn |
| Mar 31, 2023 | 9.60 Mn |
| Dec 31, 2022 | 9.60 Mn |
| Sep 30, 2022 | 9.60 Mn |
| Jun 30, 2022 | 9.60 Mn |
| Mar 31, 2022 | 9.60 Mn |
| Dec 31, 2021 | 9.60 Mn |
| Sep 30, 2021 | 9.60 Mn |
| Jun 30, 2021 | 9.60 Mn |